Updated: January 12, 2026
How Does Exemestane Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

- Why Does Estrogen Matter in Breast Cancer?
- What Is Aromatase and Why Does It Matter?
- How Exemestane Shuts Down Aromatase — The 'Suicide Inhibitor' Mechanism
- Why 'Irreversible' Matters: Exemestane vs. Anastrozole vs. Letrozole
- Why Exemestane's Mechanism Explains Its Side Effects
- Why You Need to Take It Every Day
- The Bottom Line
Overview
Exemestane permanently switches off an enzyme that makes estrogen. Here's how it works, why it's different from other aromatase inhibitors, and what that means for you.
Is Exemestane in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Exemestane near you.
If you're taking exemestane (Aromasin) for breast cancer, you may be curious about how it actually works inside your body. The mechanism is both elegant and powerful — and understanding it can help you make sense of why you need to take it every day and why some side effects occur. Here's the mechanism of action explained in plain English.
Why Does Estrogen Matter in Breast Cancer?
Not all breast cancers are the same. About 70–80% of breast cancers are hormone receptor-positive — meaning they have estrogen receptors (ER) on their surface. Estrogen acts like a key that fits into these receptors and signals the cancer cells to grow and divide. If you can significantly reduce the amount of estrogen in the body, you essentially cut off the cancer's fuel supply and slow or stop its growth.
Check live stock now.
What Is Aromatase and Why Does It Matter?
Aromatase is an enzyme — a biological catalyst — that converts androgens (male hormones like androstenedione and testosterone) into estrogens (female hormones like estradiol and estrone). Before menopause, the ovaries are the primary source of estrogen. After menopause, the ovaries stop producing estrogen, but the body still makes it — in body fat, the adrenal glands, and other tissues — using the aromatase enzyme.
This post-menopausal estrogen production — while much lower than before menopause — is still enough to fuel ER-positive breast cancer growth. That's where aromatase inhibitors like exemestane come in.
How Exemestane Shuts Down Aromatase — The 'Suicide Inhibitor' Mechanism
Exemestane is classified as a "suicide inhibitor" or, more formally, an "irreversible steroidal aromatase inactivator." Here's what that means:
- Exemestane disguises itself. Because exemestane is a steroidal molecule, it resembles androstenedione — one of the natural substrates that aromatase normally works on. The enzyme doesn't recognize the danger.
- The enzyme "bites" the bait. Aromatase binds to exemestane, thinking it's a normal substrate to process.
- The binding is permanent. Unlike anastrozole and letrozole (which temporarily block aromatase), exemestane forms an irreversible chemical bond with the enzyme's active site. The enzyme is permanently destroyed — it cannot release exemestane and go back to making estrogen.
- Estrogen production crashes. At the standard 25 mg daily dose, exemestane suppresses plasma estrogen levels by 85–95% and reduces whole-body aromatization by approximately 98% in postmenopausal women with breast cancer.
Why 'Irreversible' Matters: Exemestane vs. Anastrozole vs. Letrozole
There are three FDA-approved aromatase inhibitors for breast cancer. All three dramatically reduce estrogen, but their binding mechanisms differ:
- Anastrozole and letrozole are nonsteroidal and bind reversibly to aromatase. They block the enzyme while they're present, but the enzyme can recover when the drug is gone. New aromatase enzyme molecules produced by the body will eventually restore some estrogen production.
- Exemestane binds irreversibly. Once an aromatase enzyme molecule is inactivated by exemestane, it is permanently destroyed. The body must synthesize entirely new aromatase molecules to restore any estrogen production — a process that takes days. Maximal estrogen suppression with exemestane persists for 4–5 days after a single dose.
This irreversibility is clinically significant: it means exemestane and the nonsteroidal AIs are only partially cross-resistant. Patients whose disease progressed on anastrozole or letrozole may still respond to exemestane, and vice versa. This is one reason your oncologist might specifically choose exemestane after failure of another AI.
Why Exemestane's Mechanism Explains Its Side Effects
Understanding exemestane's mechanism makes its side effects make sense:
- Hot flashes and night sweats: Estrogen regulates body temperature. With estrogen levels reduced by 85–95%, the body's temperature regulation is disrupted — producing the classic vasomotor symptoms.
- Bone loss: Estrogen plays a critical role in maintaining bone density. Without it, bones thin over time (osteopenia, then osteoporosis).
- Joint pain and vaginal dryness: Estrogen also influences joint lubrication and vaginal tissue health. Low estrogen causes the stiffness and dryness many patients experience.
- Mild androgenic effects: Because exemestane is structurally related to androgens (male hormones), at very high doses it can have mild androgenic properties. At the standard 25 mg therapeutic dose, these effects are minimal.
Why You Need to Take It Every Day
Even though exemestane permanently destroys aromatase molecules, your body continuously produces new aromatase. Taking exemestane daily ensures a continuous supply of the drug to inactivate newly made aromatase molecules before they can produce significant amounts of estrogen. Missing doses regularly allows aromatase to partially recover and estrogen levels to creep back up.
Found
Rate
on average
The Bottom Line
Exemestane works by permanently disabling the enzyme that makes estrogen, cutting off the fuel supply for hormone-sensitive breast cancer cells. This irreversible mechanism makes it uniquely effective for patients who have progressed on other aromatase inhibitors. To understand the side effects that come with this powerful estrogen suppression, read our guide on exemestane side effects: what to expect. And if you're having trouble finding it at a pharmacy, medfinder.com can help.
Frequently Asked Questions
Exemestane permanently inactivates the aromatase enzyme, which is responsible for converting androgens into estrogen in postmenopausal women. By irreversibly destroying aromatase, exemestane reduces plasma estrogen levels by 85–95% at the standard 25 mg daily dose, cutting off the estrogen supply that hormone-sensitive breast cancer cells need to grow.
Exemestane is a steroidal aromatase inhibitor that permanently inactivates the aromatase enzyme (irreversible inhibition). Anastrozole and letrozole are nonsteroidal aromatase inhibitors that reversibly block aromatase — they work while present but the enzyme recovers when the drug is gone. This difference means exemestane and the nonsteroidal AIs are only partially cross-resistant, so switching between classes can still work after failure of the other type.
Exemestane is called a suicide inhibitor because it permanently destroys the enzyme it targets. The aromatase enzyme binds to exemestane (mistaking it for a normal substrate), forms an irreversible chemical bond, and is permanently inactivated — it cannot recover. This is analogous to the enzyme 'committing suicide' by binding to the drug.
Maximal estrogen suppression from a single dose of exemestane persists for 4–5 days because of the irreversible nature of its enzyme binding. However, because the body continuously produces new aromatase molecules, daily dosing is required to maintain consistent estrogen suppression over the long term.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Exemestane also looked for:
More about Exemestane
37,512 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





